Current status and trend of clinical development of orphan drugs in China

BACKGROUND: Rare diseases have been increasingly recognized as unmet medical and health needs worldwide; a growing demand for the development of orphan drugs emerges subsequently. Therefore, it is of great interest for both the Chinese regulatory agency and pharmaceutical companies to keep tract on...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Ziling, Jiang, Wengao, Yan, Bo, Jiang, Junhao, Zheng, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327367/
https://www.ncbi.nlm.nih.gov/pubmed/35897012
http://dx.doi.org/10.1186/s13023-022-02440-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327367/
https://www.ncbi.nlm.nih.gov/pubmed/35897012
http://dx.doi.org/10.1186/s13023-022-02440-4

Ejemplares similares